CD155, or PVR, is involved in many cellular processes, e.g., cell adhesion and tumour immune escape, but it can also result in immune activation by binding its receptor DNAM1 on NK cells; thus, it is of great interest for immunotherapy [26,27,28,29]. The gene discussed is CD226; the disease is neoplasm.